Cipla

The acquisition of 21.85 per cent stake on a fully diluted basis will be completed in two stages  

The authority has fixed prices for 40 different formulations produced by 12 manufacturers which applied for the same by submitting…

Cipla is the “first approved applicant” for such CGT and, is therefore, eligible for 180 days of CGT exclusivity which will begin…

Phase-3 clinical study for generic version has been completed in the first attempt, the company reported

Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead manufacturing process…

As a collaborative effort with industry, Hyderabad-based CSIR-IICT transferred the entire process and significant quantities of…

Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs

The company launched a spate of relief efforts for advance testing to safeguard healthcare providers and extend humanitarian care…

Rahul Agarwal, Director, Wealth Discovery, explains how the once beaten-down sector, has recently witnessed sharp uptick with…

Cipla’s Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, is the first AB-rated generic therapeutic equivalent version…